Daniel Knappe1,2, Natalja Kabankov1,2, Nicole Herth1,2, Ralf Hoffmann1,2. 1. Institute of Bioanalytical Chemistry, Faculty of Chemistry & Mineralogy, Universität Leipzig, Deutscher Platz 5, 04103 Leipzig, Germany. 2. Center for Biotechnology & Biomedicine, Universität Leipzig, Deutscher Platz 5, 04103 Leipzig, Germany.
Abstract
AIM: Organisms express a set of antimicrobial peptides (AMP) to protect the host against invading microbes by targeting their membranes or intracellular structures. Structurally optimized proline-rich AMPs (PrAMPs) are substantially more efficient in murine infection models than previously assumed from in vitro activities. Thus, we hypothesized that PrAMPs act synergistically with lytic AMPs intrinsically produced in hosts in response to an infection. METHODS & RESULTS: Synergistic effects between lytic murine cathelicidin-related AMP (CRAMP) and apidaecin- and oncocin-derivatives were studied in chequerboard assays. Evaluation of fractional inhibitory concentration indices revealed synergies against Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa. CONCLUSION: CRAMP synergistically enhances the activity of proline-rich AMPs, which will allow evaluating their therapeutic potential more precisely in vitro.
AIM: Organisms express a set of antimicrobial peptides (AMP) to protect the host against invading microbes by targeting their membranes or intracellular structures. Structurally optimized proline-rich AMPs (PrAMPs) are substantially more efficient in murineinfection models than previously assumed from in vitro activities. Thus, we hypothesized that PrAMPs act synergistically with lytic AMPs intrinsically produced in hosts in response to an infection. METHODS & RESULTS: Synergistic effects between lytic murinecathelicidin-related AMP (CRAMP) and apidaecin- and oncocin-derivatives were studied in chequerboard assays. Evaluation of fractional inhibitory concentration indices revealed synergies against Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa. CONCLUSION:CRAMP synergistically enhances the activity of proline-rich AMPs, which will allow evaluating their therapeutic potential more precisely in vitro.
Authors: Maria S Zharkova; Dmitriy S Orlov; Olga Yu Golubeva; Oleg B Chakchir; Igor E Eliseev; Tatyana M Grinchuk; Olga V Shamova Journal: Front Cell Infect Microbiol Date: 2019-04-30 Impact factor: 5.293
Authors: Riccardo Sola; Mario Mardirossian; Bertrand Beckert; Laura Sanghez De Luna; Dennis Prickett; Alessandro Tossi; Daniel N Wilson; Marco Scocchi Journal: Int J Mol Sci Date: 2020-10-06 Impact factor: 5.923
Authors: Eszter Ostorhazi; Ralf Hoffmann; Nicole Herth; John D Wade; Carl N Kraus; Laszlo Otvos Journal: Front Chem Date: 2018-08-21 Impact factor: 5.221